These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9619782)

  • 1. Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
    Nakamura T; Hashimoto Y; Kokuryo T; Inui KI
    Pharm Res; 1998 May; 15(5):734-8. PubMed ID: 9619782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
    Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
    J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cilastatin on renal handling of vancomycin in rats.
    Kusama M; Yamamoto K; Yamada H; Kotaki H; Sato H; Iga T
    J Pharm Sci; 1998 Sep; 87(9):1173-6. PubMed ID: 9724573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephrotoxicity and drug interaction of vancomycin (2)].
    Toyoguchi T; Nakagawa Y
    Nihon Yakurigaku Zasshi; 1996 May; 107(5):225-35. PubMed ID: 8690304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does nephrotoxicity develop less frequently when vancomycin is combined with imipenem-cilastatin than with meropenem? A comparative study.
    Hakeam HA; AlAnazi L; Mansour R; AlFudail S; AlMarzouq F
    Infect Dis (Lond); 2019 Aug; 51(8):578-584. PubMed ID: 31122098
    [No Abstract]   [Full Text] [Related]  

  • 6. Flucloxacillin worsens while imipenem-cilastatin protects against vancomycin-induced kidney injury in a translational rat model.
    Pais GM; Marianski S; Valdez K; Melicor RP; Liu J; Rohani R; Chang J; Tong SYC; Davis JS; Scheetz MH
    Br J Pharmacol; 2024 Mar; 181(5):670-680. PubMed ID: 37696768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fosfomycin on glycopeptide antibiotic-induced nephrotoxicity in rats.
    Yoshiyama Y; Yazaki T; Wong PC; Beauchamp D; Kanke M
    J Infect Chemother; 2001 Dec; 7(4):243-6. PubMed ID: 11810591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems].
    Kouda M
    Jpn J Antibiot; 1993 Feb; 46(2):142-53. PubMed ID: 8331774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
    Norrby SR; Burman LA; Sassella D; Corigli R; Cassinelli G; Franceschi G; Dornbusch K
    J Antimicrob Chemother; 1990 Mar; 25(3):371-83. PubMed ID: 2338416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephrotoxicity and drug interaction of vancomycin].
    Toyoguchi T; Nakagawa Y; Watanabe H
    Nihon Yakurigaku Zasshi; 1996 Feb; 107(2):53-66. PubMed ID: 8721008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein.
    Im DS; Shin HJ; Yang KJ; Jung SY; Song HY; Hwang HS; Gil HW
    Toxicol Lett; 2017 Aug; 277():9-17. PubMed ID: 28549670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to imipenem/cilastatin causes nephrotoxicity and even urolithiasis in Wistar rats.
    Tahri A; Lahyani A; Kallel R; Ayadi F; Boudawara T; Sahnoun Z
    Toxicology; 2018 Jul; 404-405():59-67. PubMed ID: 29775647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilastatin protects against imipenem-induced nephrotoxicity
    Huo X; Meng Q; Wang C; Zhu Y; Liu Z; Ma X; Ma X; Peng J; Sun H; Liu K
    Acta Pharm Sin B; 2019 Sep; 9(5):986-996. PubMed ID: 31649848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.
    Totsuka K; Shiseki M; Kikuchi K; Matsui Y
    J Antimicrob Chemother; 1999 Oct; 44(4):455-60. PubMed ID: 10588305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity.
    Humanes B; Jado JC; Camaño S; López-Parra V; Torres AM; Álvarez-Sala LA; Cercenado E; Tejedor A; Lázaro A
    Biomed Res Int; 2015; 2015():704382. PubMed ID: 26504822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of fosfomycin and tobramycin on vancomycin-induced nephrotoxicity.
    Marre R; Schulz E; Hedtke D; Sack K
    Infection; 1985; 13(4):190-2. PubMed ID: 4044046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
    Singlas E
    Presse Med; 1990 Apr; 19(13):598-605. PubMed ID: 2139939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine release induced by antimicrobial agents and effects of antimicrobial agents on vancomycin-induced histamine release from rat peritoneal mast cells.
    Toyoguchi T; Ebihara M; Ojima F; Hosoya J; Shoji T; Nakagawa Y
    J Pharm Pharmacol; 2000 Mar; 52(3):327-31. PubMed ID: 10757422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity.
    Hori Y; Aoki N; Kuwahara S; Hosojima M; Kaseda R; Goto S; Iida T; De S; Kabasawa H; Kaneko R; Aoki H; Tanabe Y; Kagamu H; Narita I; Kikuchi T; Saito A
    J Am Soc Nephrol; 2017 Jun; 28(6):1783-1791. PubMed ID: 28052987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal clearance of imipenem in children.
    Jacobs RF; Kearns GL; Brown AL; Trang JM; Kluza RB
    Eur J Clin Microbiol; 1984 Oct; 3(5):471-4. PubMed ID: 6594236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.